Clinical trial
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
NCT00033111 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00033111 |
|---|---|
| Title | A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 |
| Official title | Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of California, Los Angeles |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Cabergoline, Placebo |
| Enrollment | 140 |
| Start date | Jun 1, 2001 |
| Completion | Apr 1, 2004 |
| First posted | Apr 8, 2002 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: